Is Merck & Co., Inc. (MRK) the Best Dow Stock?
From Yahoo Finance: 2025-05-07 16:55:00
In a recent article, we ranked the best and worst Dow stocks. Merck & Co., Inc. (MRK) is a healthcare company and ranks 17th on the list. Despite potential, AI stocks may offer higher returns in a shorter timeframe, with one AI stock showing promising gains.
Merck & Co., Inc. is a healthcare company with 91 hedge fund holders and a short interest of 1.67%. Revenue is expected to be between $64.1 billion to $65.6 billion, with a revised EPS guidance of $8.82 to $8.97. The company is investing $1 billion in a new biologics facility in Delaware, creating jobs and producing advanced therapies.
The Dow Jones Industrial Average represents the top 30 US companies, with some outperforming due to innovation and economic trends. Our ranking of Dow stocks is based on hedge fund holdings and short interest, with Merck & Co., Inc. falling in the middle. AI stocks may present better opportunities for higher returns in a shorter timeframe.